Covid-19 Updates | Targeted Protein Degradation Enabling Technologies Market is anticipated to be worth over USD 3.3 billion by 2030
Access Full Report: https://www.rootsanalysis.com/....reports/view_documen
Covid-19 Updates | Cancer Biomarkers Market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis
Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions
Read More: https://www.rootsanalysis.com/....reports/view_documen
Roots Analysis has announced the addition of “RNAi Therapeutics Market, 2021-2030” report to its list of offerings.
The concept of RNA interference (RNAi) was identified in the 1980s. It is based on the selective silencing of specific sequences of mRNA, thereby, inhibiting the ability to translate into disease causing proteins.
Significant advancements in the developmental pipeline across various oncological disorders, infectious diseases and genetic disorders have amplified the interest of various pharmaceutical establishments and have inspired research groups across the world, to focus their efforts on the development of RNAi therapeutics. Further, there are multiple pipeline candidates in mid to late-stage (phase II and above) trials and are anticipated to enter the market over the next 5-10 years.
Read Detailed Analysis: https://www.rootsanalysis.com/....reports/view_documen
Covid-19 Updates | Preventive Vaccines Market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis
Although vaccines were solely responsible for the global eradication of smallpox (198 and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a threat; COVID-19 has been recently added to the list
Know more: https://www.rootsanalysis.com/....reports/view_documen
Covid-19 Updates | Prefilled Syringes Market is estimated to be worth over USD 2.5 billion in 2030, predicts Roots Analysis
Despite having been available for more than two decades, the demand for prefilled syringes continues to grow, given the numerous benefits they offer over conventional injectable drug delivery systems
Read More: https://www.rootsanalysis.com/....reports/view_documen
